Scisparc Ltd

SPRCStocksPharmaceuticals MajorIsraelNasdaqUSD

Price

$4.65

Today

-4.2%

YTD

-60.9%

About

SciSparc Ltd is a clinical-stage pharmaceutical company developing cannabinoid-based therapies for central nervous system disorders. It operates in the US and Israeli biotechnology sector, targeting unmet medical needs through clinical trials. The company’s pipeline includes SCI-110 for Tourette syndrome and Alzheimer’s agitation, SCI-210 for autism spectrum disorder, and SCI-160 for pain. SciSparc Ltd is managed by SciSparc Incorporated. Its innovative drug candidates aim to enhance treatment efficacy. Add this stock to your eToro watchlist to receive news and updates on the SPRC share price. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart

Closing price history for SPRC (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-0.02

P/S (TTM)0.27

P/B (TTM)0.05

Market cap$3.27M

Cap tierMicro-cap

Industry avg P/E-43.38

Profitability

Gross margin46.38%

EBIT margin-1022.08%

Net margin-721.77%

ROE-196.55%

ROA-135.56%

Earnings & Revenue

Revenue (TTM)$856,000.00

Revenue growth (1Y)-34.5%

EPS (TTM)-$231.49

Free cash flow$-4.14M

Total debt$366,000.00

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.86

Employees3

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.